A recent study has shown that the CLSP activity is reduced in AD patients and the APPswe/PSEN1dE9 mice, and the restoration of the CLSP activity reverses memory impairment and hippocampal synaptic loss in the APPswe/PSEN1dE9 mice (20). The gene discussed is CALML5; the disease is memory impairment.